CSL - PE Price to Earnings

Stock Price
97.96
Daily Change
0.70 0.72%
Monthly
-28.78%
Yearly
-59.49%
Q2 Forecast
96.11

CSL reported 16.16 in PE Price to Earnings for its fiscal semester ending in December of 2025.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cara Therapeutics 27.77 117.09 Sep/2021
CSL 16.16 9.59 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
TherapeuticsMD 0.75 3.3 Mar/2023